Advancing Research in Augmentative and Alternative Communication (AAC) (R01, R21 Clinical Trial Optional)

Funding Agency:
National Institutes of Health

This funding opportunity announcement (FOA) seeks Research Project Grants (R01) applications on Augmentative and Alternative Communication (AAC) to advance our scientific knowledge in the evaluation and treatment of individuals with severe speech and physical impairments (SSPI).  AAC is a set of tools and strategies that an individual uses to solve everyday communicative challenges. This FOA is for R01s only and encourages a range of research inclusive of basic, clinical, and translational.  It runs in parallel with an R21 of identical scientific scope, PA-19-046.


  • R01 Due Dates: Feb. 5, Jun. 5, Oct. 5
  • R21 Due Dates: Feb. 16, Jun. 16, Oct. 16
  • AIDS Due Dates: Jan. 7,May 7, Sep.7

PA-19-047 Expiration Date January 08, 2022




Medical - Basic Science
Medical - Clinical Science
Medical - Translational

External Deadline

October 5, 2021